Publications by authors named "G Freestone"

Article Synopsis
  • Therapeutic oligonucleotides are modified to improve their ability to bind target RNA, primarily by enhancing binding affinity through changes in the sugar conformation.
  • Researchers found that introducing hydrocarbon bridges between nucleotides can improve the alignment of the nucleic acids, making them more effective at base-pairing.
  • The study specifically details the creation of locked nucleic acid trimers using alkylphosphonate tethers, which limit the movement of both the sugar and the sugar-phosphate backbone to further boost hybridization efficiency.
View Article and Find Full Text PDF

We recently described a chemical strategy to pre-organize a trinucleotide subunit in a conformation suitable for Watson-Crick base pairing for modulating the binding kinetics of single-stranded oligonucleotides (ONs) using bis-phosphonate esters bridging hydrocarbon tethers to provide 11- and 15-membered macrocyclic analogues. In this manuscript, we describe the synthesis of all eight P-stereoisomers of macrocyclic 12-, 13-, 14-, and 16-membered hydrocarbon-bridged nucleotide trimers, their incorporation into ONs, and biophysical characterization of the modified ONs. The size of the macrocyclic tether and configuration at phosphorus had profound effects on hybridization kinetics.

View Article and Find Full Text PDF

Antisense oligonucleotides (ASOs) that mediate RNA target degradation by RNase H1 are used as drugs to treat various diseases. Previously we found that introduction of a single 2'--methyl (2'-OMe) modification in position 2 of the central deoxynucleotide region of a gapmer phosphorothioate (PS) ASO, in which several residues at the termini are 2'-methoxyethyl, 2' constrained ethyl, or locked nucleic acid, dramatically reduced cytotoxicity with only modest effects on potency. More recently, we demonstrated that replacement of the PS linkage at position 2 or 3 in the gap with a mesyl-phosphoramidate (MsPA) linkage also significantly reduced toxicity without meaningful loss of potency and increased the elimination half-life of the ASOs.

View Article and Find Full Text PDF

The binding affinity of therapeutic oligonucleotides (ONs) for their cognate RNA is determined by the rates of association () and dissociation (). Single-stranded ONs are highly flexible and can adopt multiple conformations in solution, some of which may not be conducive for hybridization. We investigated if restricting rotation around the sugar-phosphate backbone, by tethering two adjacent backbone phosphonate esters using hydrocarbon bridges, can modulate hybridization kinetics of the modified ONs for complementary RNA.

View Article and Find Full Text PDF
Article Synopsis
  • - The PS modification increases the stability and protein binding of gapmer antisense oligonucleotides (ASOs) while allowing RNaseH1 activity; researchers tested the impact of adding mesyl-phosphoramidate (MsPA) linkages on various ASO properties.
  • - Although substituting PS with MsPA didn’t compromise chemical stability or RNA affinity, it did reduce the overall activity of ASOs; however, certain substitutions were shown to minimize immune response and toxicity in cells and mice.
  • - The combination of PS and MsPA linkages presents a promising new platform for developing ASO drugs that are more potent, have a better safety profile, and maintain their effectiveness for longer periods, similar to enhanced si
View Article and Find Full Text PDF